相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Increased EGFRvIII Epitope Accessibility after Tyrosine Kinase Inhibitor Treatment of Glioblastoma Cells Creates More Opportunities for Immunotherapy
Cezary Treda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies
Amin Daei Sorkhabi et al.
FRONTIERS IN IMMUNOLOGY (2023)
Phenotypical Flexibility of the EGFRvIII-Positive Glioblastoma Cell Line and the Multidirectional Influence of TGFβ and EGF on These Cells-EGFRvIII Appears as a Weak Oncogene
Aneta Wlodarczyk et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma
Joseph H. Choe et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Web-based LinRegPCR: application for the visualization and analysis of (RT)-qPCR amplification and melting data
Andreas Untergasser et al.
BMC BIOINFORMATICS (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
A way to understand idiopathic senescence and apoptosis in primary glioblastoma cells - possible approaches to circumvent these phenomena
Karolina Janik et al.
BMC CANCER (2019)
EGFRvIII: An Oncogene with Ambiguous Role
Adrianna Rutkowska et al.
JOURNAL OF ONCOLOGY (2019)
Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies
Zhenyi An et al.
ONCOGENE (2018)
Cyclic trans-phosphorylation in a homodimer as the predominant mechanism of EGFRvIII action and regulation
Wojciech Stec et al.
Oncotarget (2018)
Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014
Quinn T. Ostrom et al.
JAMA ONCOLOGY (2018)
Chimeric antigen receptor T-cell therapy for glioblastoma
Analiz Rodriguez et al.
TRANSLATIONAL RESEARCH (2017)
Low Incidence along with Low mRNA Levels of EGFRvIII in Prostate and Colorectal Cancers Compared to Glioblastoma
Joanna Peciak et al.
JOURNAL OF CANCER (2017)
Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors
Joerg Felsberg et al.
CLINICAL CANCER RESEARCH (2017)
EGFR Activation Leads to Cell Death Independent of PI3K/AKT/mTOR in an AD293 Cell Line
Cezary Treda et al.
PLOS ONE (2016)
Cell line with endogenous EGFRvIII expression is a suitable model for research and drug development purposes
Wojciech J. Stec et al.
ONCOTARGET (2016)
Changes in the EGFR amplification and EGFRvIII expression between paired primary and recurrent glioblastomas
Martin J. van den Bent et al.
NEURO-ONCOLOGY (2015)
The Human Glioblastoma Cell Culture Resource: Validated Cell Models Representing All Molecular Subtypes
Yuan Xie et al.
EBIOMEDICINE (2015)
The Failure in the Stabilization of Glioblastoma-Derived Cell Lines: Spontaneous In Vitro Senescence as the Main Culprit
Ewelina Stoczynska-Fidelus et al.
PLOS ONE (2014)
The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered
Hui K. Gan et al.
FEBS JOURNAL (2013)
EGFRvIII gene rearrangement is an early event in glioblastoma tumorigenesis and expression defines a hierarchy modulated by epigenetic mechanisms
C. A. Del Vecchio et al.
ONCOGENE (2013)
Screening for EGFR Amplifications with a Novel Method and Their Significance for the Outcome of Glioblastoma Patients
Michal Bienkowski et al.
PLOS ONE (2013)
Recognition of Glioma Stem Cells by Genetically Modified T Cells Targeting EGFRvIII and Development of Adoptive Cell Therapy for Glioma
Richard A. Morgan et al.
HUMAN GENE THERAPY (2012)
Expression of Amphiregulin and EGFRvIII Affect Outcome of Patients with Squamous Cell Carcinoma of the Head and Neck Receiving Cetuximab-Docetaxel Treatment
Ingeborg Tinhofer et al.
CLINICAL CANCER RESEARCH (2011)
Glioblastoma-derived spheroid cultures as an experimental model for analysis of EGFR anomalies
Monika Witusik-Perkowska et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting
John C. Sok et al.
CLINICAL CANCER RESEARCH (2006)
Expression of constitutively activated EGFRvIII in non-small cell lung cancer
I Okamoto et al.
CANCER SCIENCE (2003)
Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR -: art. no. e36
MW Pfaffl et al.
NUCLEIC ACIDS RESEARCH (2002)
A new mathematical model for relative quantification in real-time RT-PCR
MW Pfaffl
NUCLEIC ACIDS RESEARCH (2001)
分享论文
